Clinical Trial Update: Effectiveness, Safety and Tolerability Study of RP-G28 for Symptoms Associated With Lactose Intolerance [Phase 2]

View source ↗

Summary

This update reports the Phase 2 results assessing the effectiveness, safety and tolerability of RP-G28 for symptoms of lactose intolerance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lactose Intolerance

Drugs mentioned

• RP-G28

Snippet

Sponsor: Ritter Pharmaceuticals, Inc. | Conditions: Lactose Intolerance | Phase 2 | Status: COMPLETED